Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

在社区获得性肺炎的成人住院患者中,非典型病原体的经验性抗生素用药覆盖范围

Información

DOI:
https://doi.org/10.1002/14651858.CD004418.pub4Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 12 septiembre 2012see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Infecciones respiratorias agudas

Copyright:
  1. Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Noa Eliakim‐Raz

    Correspondencia a: Department of Medicine E, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel

    [email protected]

  • Eyal Robenshtok

    Department of Medicine E, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel

    Sackler School of Medicine, Tel Aviv University, Ramat Aviv and Endocrinology and Metabolism Institute, Petah Tikva, Israel

  • Daphna Shefet

    Department of Medicine E, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel

  • Anat Gafter‐Gvili

    Department of Medicine E, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel

  • Liat Vidal

    Department of Medicine E, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel

  • Mical Paul

    Infectious Diseases Unit, Sackler Faculty of Medicine, Tel Aviv, Israel

  • Leonard Leibovici

    Department of Medicine E, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel

Contributions of authors

Noa Eliakim Raz (NER) co‐ordinated this updated review, guided by Leonard Leibovic (LL).
NER and Eyal Robenshtok (ER) were responsible for data collection, writing to trial authors for additional information and organizing retrieval of papers.
NER and ER were responsible for undertaking searches.
NER, ER, Daphna Shefet (DS), Anat Gafter‐Gvili (AG) and Mical Paul (MP) were responsible for screening search results, abstracting data from papers, screening retrieved papers against inclusion criteria and appraising quality of papers (the latter review author was in‐charge in case of disagreement).
NER was responsible for entering data into Review Manager 5 (RevMan).
All review authors participated in analysis and interpretation of data.
NER and ER were responsible for writing the review.

Sources of support

Internal sources

  • Rabin Medical Center ‐ Beilinson Campus, Israel.

External sources

  • EU 5th Framework: TREAT project (grant number: 1999‐11459), Not specified.

  • The Rothschild‐Caesarea Foundation “Optimal antibiotic treatment of moderate to severe infections: Integration of PCR technology and medical informatics/artificial intelligence”, Not specified.

Declarations of interest

None known.

Acknowledgements

We thank the trial authors who responded to our requests: Dr. Claude Carbon, Dr. Francois Fourrier, Dr. Daniel Genne, Dr. Hartmut Lode, Dr. Phillip Peterson, Dr. Patrick Petitpretz and Dr. Jose Sifuentes Osornio. We are indebted to Dr. Karla Soares‐Weiser for her guidance. We would like to thank Dr. Gabriel Izbicki for his translation from German and to Ms. Rika Fujia for obtaining and translating the Japanese articles. Warm thanks to the Cochrane Acute Respiratory Infections Group editorial team for their guidance throughout the review (Liz Dooley, Managing Editor) and the help devising and conducting the search (Sarah Thorning, Trials Search Co‐ordinator). We wish to thank the following people for commenting on this latest updated draft: Linda Hornbeek, Richard Taggart, Theo Verheij, Nelcy Rodriguez and Allen Cheng.

Version history

Published

Title

Stage

Authors

Version

2012 Sep 12

Empiric antibiotic coverage of atypical pathogens for community‐acquired pneumonia in hospitalized adults

Review

Noa Eliakim‐Raz, Eyal Robenshtok, Daphna Shefet, Anat Gafter‐Gvili, Liat Vidal, Mical Paul, Leonard Leibovici

https://doi.org/10.1002/14651858.CD004418.pub4

2008 Jan 23

Empiric antibiotic coverage of atypical pathogens for community‐acquired pneumonia in hospitalized adults

Review

Eyal Robenshtok, Daphna Shefet, Anat Gafter‐Gvili, Mical Paul, Liat Vidal, Leonard Leibovici

https://doi.org/10.1002/14651858.CD004418.pub3

2005 Apr 20

Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults

Review

Daphna Shefet, Eyal Robenshtok, Mical Paul, Leonard Leibovici

https://doi.org/10.1002/14651858.CD004418.pub2

2003 Oct 20

Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults

Protocol

Daphna Shefet, Mical Paul, Karla Soares‐Weiser, Leonard Leibovici

https://doi.org/10.1002/14651858.CD004418

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.